Tatva Chintan Pharma Chem Limited — Board Meeting, 16-05-2026: Outcome of Board Meeting

Tatva Chintan's Board approved consolidated Q4 & FY26 results. Full-year profit surged to Rs 57.01 Cr, with revenue at Rs 505.86 Cr. A final dividend of Rs 2 per share (20%) for FY26 was proposed, awaiting shareholder nod.